2004
Estimating the relative risk of developing melanoma in INK4A carriers
Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady M, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg C. Estimating the relative risk of developing melanoma in INK4A carriers. European Journal Of Cancer Prevention 2004, 13: 65-70. PMID: 15075790, DOI: 10.1097/00008469-200402000-00010.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCase-Control StudiesChromatography, LiquidCyclin-Dependent Kinase Inhibitor p16FemaleGerm-Line MutationHumansMaleMelanomaMiddle AgedNeoplasms, Multiple PrimaryNevusNucleic Acid DenaturationOdds RatioPilot ProjectsPolymerase Chain ReactionPrevalenceRisk FactorsSkin NeoplasmsSurveys and QuestionnairesConceptsRisk factorsRelative riskMemorial Sloan-Kettering Cancer CenterStudy designSingle primaryCancer risk factorsMultiple primary melanomasRisk of melanomaNumber of neviPigmented lesion clinicNovel study designRare germline mutationsDermatology clinicCancer CenterNew study designsPrimary melanomaLesion clinicHigh prevalencePrimary casesPatientsMultiple primariesMelanomaGermline mutationsPilot studyFair skin
2003
Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case
Pol-Rodriguez M, Crane S, Feinberg D, Glusac E, Bolognia J. Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case. JAMA Dermatology 2003, 139: 803-808. PMID: 12810518, DOI: 10.1001/archderm.139.6.803-a.Peer-Reviewed Case Reports and Technical Notes
2001
The eclipse naevus: tan centre with stellate brown rim
Schaffer J, Glusac E, Bolognia J. The eclipse naevus: tan centre with stellate brown rim. British Journal Of Dermatology 2001, 145: 1023-1026. PMID: 11899128, DOI: 10.1046/j.1365-2133.2001.04538.x.Peer-Reviewed Original ResearchPointillist nevi
Huynha P, Glusac E, Bolognia J. Pointillist nevi. Journal Of The American Academy Of Dermatology 2001, 45: 397-400. PMID: 11511837, DOI: 10.1067/mjd.2001.116343.Peer-Reviewed Original ResearchConceptsMelanocytic neviHistologic featuresHistologic correlatesMelanocytic nestsJunctional melanocytic nestsAtypical melanocytic neviBenign melanocytic neviBenign melanocytic lesionsCutaneous melanomaHistologic examinationPerifollicular hypopigmentationPapillary dermisMelanocytic lesionsNeviBrown globulesUnusual patternUnusual leucodermas
Bolognia J. Unusual leucodermas. Journal Of The European Academy Of Dermatology And Venereology 2001, 15: 386-387. PMID: 11763374, DOI: 10.1046/j.1468-3083.2001.00318.x.Commentaries, Editorials and LettersPartial unilateral lentiginosis with ocular involvement
Schaffer J, Lazova R, Bolognia J. Partial unilateral lentiginosis with ocular involvement. Journal Of The American Academy Of Dermatology 2001, 44: 387-390. PMID: 11174424, DOI: 10.1067/mjd.2001.107968.Peer-Reviewed Case Reports and Technical NotesPerinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris
Schaffer J, Davidson D, McNiff J, Bolognia J. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. Journal Of The American Academy Of Dermatology 2001, 44: 198-206. PMID: 11174376, DOI: 10.1067/mjd.2001.112218.Peer-Reviewed Case Reports and Technical NotesConceptsLong-term minocycline therapyCutaneous polyarteritis nodosaAntineutrophil cytoplasmic antibodyPolyarteritis nodosaMinocycline therapyCytoplasmic antibodiesSubcutaneous nodulesAcne vulgarisPerinuclear antineutrophil cytoplasmic antibodyAntinuclear antibody panelDiscontinuation of minocyclineDrug-induced lupusUnusual side effectMedium-sized arteriesLong-term treatmentAutoimmune hepatitisOral antibioticsPrednisone therapyLivedo reticularisAutoimmune syndromeAutoimmune disordersCutaneous lesionsBiopsy specimensLower extremitiesHistologic examinationSpeckled lentiginous nevus: within the spectrum of congenital melanocytic nevi.
Schaffer J, Orlow S, Lazova R, Bolognia J. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. JAMA Dermatology 2001, 137: 172-8. PMID: 11176689.Peer-Reviewed Original ResearchConceptsCongenital melanocytic neviLentiginous nevusMelanocytic neviCongenital neviSpeckled lentiginous nevusTypes of neviHistologic featuresCongenital natureClinical appearanceBiopsy specimensHistologic examinationLesionsSame lesionNatural historyPigmented lesionsNeviMultiple reportsSubtypesBirthPattern of distributionAdditional evidencePatients
2000
Treatment of lipodermatosclerosis with oxandrolone in a patientwith stanozolol-induced hepatotoxicity
Segal S, Cooper J, Bolognia J. Treatment of lipodermatosclerosis with oxandrolone in a patientwith stanozolol-induced hepatotoxicity. Journal Of The American Academy Of Dermatology 2000, 43: 558-559. PMID: 10954677, DOI: 10.1067/mjd.2000.106517.Peer-Reviewed Case Reports and Technical NotesA Figurate Papulosquamous Variant of Inflammatory Vitiligo
Lee D, Lazova R, Bolognia J. A Figurate Papulosquamous Variant of Inflammatory Vitiligo. Dermatology 2000, 200: 270-274. PMID: 10828641, DOI: 10.1159/000018374.Peer-Reviewed Case Reports and Technical NotesConceptsInflammatory vitiligoSuperficial perivascular infiltrateErythematous rimLichenoid infiltrateSerpiginous lesionsPerivascular infiltratesHistological spectrumMononuclear cellsScaly plaquesCase reportHistological correlatesVitiligoSimilar findingsClassic descriptionInfiltratesPlaquesStratum corneumLichenoidPatientsLesionsParakeratosisA pilot study using nurse education as an intervention to increase skin self-examination for melanoma.
Berwick M, Oliveria S, Luo S, Headley A, Bolognia J. A pilot study using nurse education as an intervention to increase skin self-examination for melanoma. Journal Of Cancer Education 2000, 15: 38-40. PMID: 10730802, DOI: 10.1080/08858190009528651.Peer-Reviewed Original Research
1999
Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma
Poo‐Hwu W, Ariyan S, Lamb L, Papac R, Zelterman D, Hu G, Brown J, Fischer D, Bolognia J, Buzaid A. Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma. Cancer 1999, 86: 2252-2258. PMID: 10590365, DOI: 10.1002/(sici)1097-0142(19991201)86:11<2252::aid-cncr12>3.0.co;2-q.Peer-Reviewed Original ResearchConceptsCancer stage IAmerican Joint CommitteePatient education programStage IYale Melanoma UnitSurveillance scheduleSymptomatic recurrenceMelanoma UnitSurveillance examinationsJoint CommitteeOverall survival rateStage of diseaseDetection of recurrenceAsymptomatic recurrenceAsymptomatic patientsDistant recurrenceLocoregional recurrenceHazard ratioDisease recurrenceInitial visitMore recurrencesMost recurrencesLate recurrenceMelanoma patientsRecurrence groupFlip-Top Pigment Transplantation: A Novel Transplantation Procedure for the Treatment of Depigmentation
McGovern T, Bolognia J, Leffell D. Flip-Top Pigment Transplantation: A Novel Transplantation Procedure for the Treatment of Depigmentation. JAMA Dermatology 1999, 135: 1305-1307. PMID: 10566827, DOI: 10.1001/archderm.135.11.1305.Peer-Reviewed Original ResearchA clinical approach to leukoderma
Bolognia J. A clinical approach to leukoderma. International Journal Of Dermatology 1999, 38: 568-572. PMID: 10487443, DOI: 10.1046/j.1365-4362.1999.00653.x.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
1998
The development of lentigines within segmental achromic nevi
Bolognia J, Lazova R, Watsky K. The development of lentigines within segmental achromic nevi. Journal Of The American Academy Of Dermatology 1998, 39: 330-333. PMID: 9703146, DOI: 10.1016/s0190-9622(98)70383-4.Peer-Reviewed Original ResearchHypopigmented common blue nevi.
Bolognia J, Glusac E. Hypopigmented common blue nevi. JAMA Dermatology 1998, 134: 754-6. PMID: 9645654, DOI: 10.1001/archderm.134.6.754.Peer-Reviewed Original ResearchMelanoma × macrophage hybrids with enhanced metastatic potential
Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, Madison McNiff J, Platt J, Bermudes D, Pawelek J. Melanoma × macrophage hybrids with enhanced metastatic potential. Clinical & Experimental Metastasis 1998, 16: 299-312. PMID: 9626809, DOI: 10.1023/a:1006557228604.Peer-Reviewed Original ResearchConceptsHigh metastatic potentialMetastatic potentialMelanoma cellsTumor-infiltrating leukocytesParental melanoma cellsLow metastatic potentialB16F10 melanoma cellsFibroblast-conditioned mediumCloudman S91 mouse melanoma cellsMetastatic melanoma cellsS91 mouse melanoma cellsVascular invasionMetastatic melanomaPrimary tumorNormal miceMelanoma metastasesEnhanced metastasisMetastasisDistant organsUseful new modelMouse melanoma cellsHigher chemotaxisMetastatic linesHuman macrophagesTumor cellsBubble hair – a possible explanation for its distribution
Krasnoff J, Glusac E, Bolognia J. Bubble hair – a possible explanation for its distribution. International Journal Of Dermatology 1998, 37: 380-382. PMID: 9620487, DOI: 10.1046/j.1365-4362.1998.00463.x.Peer-Reviewed Case Reports and Technical Notes
1997
Regional Isolated Perfusion of Extremities for Melanoma: A 20-Year Experience with Drugs Other than L-Phenylalanine Mustard
Ariyan S, Poo W, Bolognia J. Regional Isolated Perfusion of Extremities for Melanoma: A 20-Year Experience with Drugs Other than L-Phenylalanine Mustard. Plastic & Reconstructive Surgery 1997, 99: 1023-1029. PMID: 9091898, DOI: 10.1097/00006534-199704000-00016.Peer-Reviewed Original ResearchConceptsL-phenylalanine mustardRegional isolated perfusionIsolated limb perfusionIsolated perfusionLimb perfusionUpper extremityLower extremitiesTherapeutic isolated limb perfusionNonfatal pulmonary embolusRegional treatment modalityEvidence of diseaseHigh-dose chemotherapyHigh-risk melanomaNumber of patientsDifficult management problemDisease-free controlsTechnique of perfusionLimb recurrenceMeaningful palliationRepeat perfusionsAggressive treatmentPulmonary emboliDose chemotherapyRecurrent melanomaSerious complications
1996
Clinicopathologic Findings in the Bannayan-Riley-Ruvalcaba Syndrome
Fargnoli M, Orlow S, Semel-Concepcion J, Bolognia J. Clinicopathologic Findings in the Bannayan-Riley-Ruvalcaba Syndrome. JAMA Dermatology 1996, 132: 1214-1218. PMID: 8859033, DOI: 10.1001/archderm.1996.03890340078012.Peer-Reviewed Original ResearchConceptsBannayan-RileyRuvalcaba syndromeBiopsy specimensVascular malformationsCentral nervous system vascular malformationsCharacteristic cutaneous findingsNormal ventricular sizeMultiple subcutaneous lipomasStriking clinical findingNumber of melanocytesCutaneous findingsAcanthosis nigricansClinical findingsClinicopathologic findingsVentricular sizeVerrucous changesHistologic findingsHistological featuresFacial papulesIntestinal polyposisSubcutaneous lipomaAutosomal dominant fashionEpidermal hyperplasiaClinical overlapFacial lesions